Related Experiment Video

Updated: Jul 2, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated

Volker Ruppert1, Thomas Meyer, Sabine Pankuweit

  • 1Department of Cardiology, University of Marburg, Baldingerstrasse, Marburg, Germany.

The Journal of Thoracic and Cardiovascular Surgery
|August 12, 2008
PubMed

Insights

Gene expression profiling of heart muscle biopsies reveals distinct subtypes of dilated cardiomyopathy, highlighting its heterogeneity and overlap with inflammatory heart disease. This aids in differential diagnosis of heart failure.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Genomics

Background:

  • Heart failure diagnosis can be challenging, particularly differentiating between various cardiomyopathies.
  • Endomyocardial biopsy (EMB) offers tissue for detailed analysis.
  • Gene expression profiling (GEP) of EMB may reveal molecular differences not apparent histopathologically.

Purpose of the Study:

  • To investigate gene expression profiles in EMB specimens from patients with different cardiomyopathies.
  • To identify distinct molecular subtypes within dilated cardiomyopathy (DCM).
  • To assess the utility of GEP in improving the differential diagnosis of heart failure.

Main Methods:

  • Left ventricular EMBs were obtained from 50 heart failure patients.
  • Samples were classified as DCM, inflammatory cardiomyopathy, myocarditis, or pericarditis.
  • Complementary DNA was hybridized to microarrays, and differentially expressed genes were hierarchically clustered.

Main Results:

  • Two distinct GEP patterns were identified in DCM samples.
  • One pattern was unique to DCM and inflammatory cardiomyopathy; another resembled inflammatory heart disease.
  • DCM showed reduced myocardial toll-like receptor 9 expression, linked to cardiomyocyte loss.
  • GEP identified transcriptionally distinct DCM subentities that were histopathologically similar.

Conclusions:

  • Dilated cardiomyopathy is a heterogeneous disease with significant transcriptional overlap with inflammatory heart disease.
  • GEP of EMB is a valid tool for detecting DCM subentities.
  • Transcriptional data suggests immune activation in some DCM cases without detectable cellular infiltration.
Abstract

More Related Videos

Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes08:23

Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes

Published on: December 28, 2011

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...